ImaginAb
Clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Nextech Invest(exited)
Cycad Group(exited)
Momentum Bioscience(exited)
Jim Pallotta(exited)
Adage Capital(exited)
Norgine Ventures(exited)
Theravance(exited)
Novartis Venture Fund(exited)
Mérieux Equity Partners(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.